Supriya Lifescience Ltd

  • BSE Code : 543434
  • NSE Symbol : SUPRIYA
  • ISIN : INE07RO01027
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 656.00 35.25(5.68%)

Open Price ()

621.75

Prev. Close ()

620.75

Volume (No’s)

403,554

Market Cap ()

5,279.67

Low Price ()

620.00

High Price ()

660.00

 

Corporate Announcement

25-Mar-2026 Supriya Lifescience Limited - Trading Window
24-Mar-2026 Supriya Lifescience Limited - Change in Director(s)
13-Mar-2026 Supriya Lifescience Limited - Reply to Clarification- Financial results
10-Mar-2026 Supriya Lifescience Limited - Shareholders meeting
17-Feb-2026 Supriya Lifescience Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Stock Summary

Market Cap(₹Cr.)

4,993.56

P/E (TTM)

26.91

Book value ()

134.41

Div Yield (%)

0.16

EPS (TTM)

23.06

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

627.77

Resistance 2

634.78

Support 1

615.87

Support 2

610.98

Moving Average

30 Days

602.75

50 Days

630.59

100 Days

681.79

200 Days

694.98

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Supriya Lifescience Ltd 5,286.92 28.49 5.92 270.73 0.15 23.06
Sun Pharmaceutical Indust.. 400,496.99 91.76 17.11 7162.05 0.96 18.19
Divis Laboratories Ltd 166,938.59 64.89 10.27 3332 0.48 96.91
Torrent Pharmaceuticals L.. 138,109.43 61.84 14.42 3583.06 0.15 65.99
Lupin Ltd 105,496.37 19.08 3.81 5569.31 0.52 120.95

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 5061600 6.29
Total Institutions 4588032 5.70
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 2039387 2.53
Total Promoters 54967825 68.30
Total Public & others 13825956 17.18
Total 80482800 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'. The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007. Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai.

The Company commenced operations in April, 2008. It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs). The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development. The company have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively,of the API exports from India, between Fiscal 2017 and 2020.

The company is among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume.The company's produ...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew